BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/25/2022 9:22:03 AM | Browse: 808 | Download: 1681
 |
Received |
|
2021-04-30 17:56 |
|
Peer-Review Started |
|
2021-04-30 17:58 |
|
First Decision by Editorial Office Director |
|
2021-06-30 06:04 |
|
Return for Revision |
|
2021-06-30 06:04 |
|
Revised |
|
2021-07-14 16:15 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-01-15 02:42 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-01-17 05:29 |
|
Articles in Press |
|
2022-01-17 05:29 |
|
Edit the Manuscript by Language Editor |
|
2022-01-14 02:21 |
|
Typeset the Manuscript |
|
2022-01-24 02:55 |
|
Publish the Manuscript Online |
|
2022-01-25 09:22 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Viral hepatitis: Innovations and expectations
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Simona Leoni, Alberto Casabianca, Benedetta Biagioni and Ilaria Serio |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Simona Leoni, MD, PhD, Doctor, Doctor, Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna 40138, Italy. simona.leoni@aosp.bo.it |
| Key Words |
Viral hepatitis; Chronic liver disease; Treatments; Antiviral; Immunotherapy; Vaccination |
| Core Tip |
Viral hepatitis is a known worldwide health problem, with a risk of evolution in chronic liver disease. Novel therapies have shown increased efficacy in curing the hepatitis C virus (HCV), with the goal of HCV elimination by 2030. New concurrent interest in hepatitis B virus (HBV) curative therapies has been recently registered: New antivirals targeting different steps of HBV life cycle and immune modulators. In hepatitis D, the improved knowledge of the life cycle has facilitated the development of some direct-acting agents, more effective than interferon-based therapies. New studies are required to improve the treatment of hepatitis E. |
| Publish Date |
2022-01-25 09:22 |
| Citation |
Leoni S, Casabianca A, Biagioni B, Serio I. Viral hepatitis: Innovations and expectations. World J Gastroenterol 2022; 28(5): 517-531 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i5/517.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i5.517 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
